FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

18066411000001100: Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Nov 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62154901000001119 Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62155001000001119 Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) Is a Product containing precisely azelastine hydrochloride 140 microgram/1 actuation conventional release nasal spray (clinical drug) true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) Has active ingredient Azelastine hydrochloride false Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) Has manufactured dose form Conventional release nasal spray true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) Has specific active ingredient Azelastine hydrochloride true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) Is a Rhinolast true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) 22 ml Has AMP True Rhinolast 140micrograms/dose nasal spray (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start